Chemoinformaics analysis of 2,6-Dimethylundecane
| Molecular Weight | 184.367 | nRot | 8 |
| Heavy Atom Molecular Weight | 156.143 | nRig | 1 |
| Exact Molecular Weight | 184.219 | nRing | 0 |
| Solubility: LogS | -2.072 | nHRing | 0 |
| Solubility: LogP | 2.281 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 41 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 40.3802 |
| nHD | 0 | BPOL | 28.0898 |
| QED | 0.542 |
| Synth | 1.744 |
| Natural Product Likeliness | 0.17 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.001 |
| HIA | 0.003 |
| CACO-2 | -4.177 |
| MDCK | 0.0000382 |
| BBB | 0.988 |
| PPB | 0.531689 |
| VDSS | 0.758 |
| FU | 0.589693 |
| CYP1A2-inh | 0.918 |
| CYP1A2-sub | 0.224 |
| CYP2c19-inh | 0.459 |
| CYP2c19-sub | 0.802 |
| CYP2c9-inh | 0.288 |
| CYP2c9-sub | 0.459 |
| CYP2d6-inh | 0.009 |
| CYP2d6-sub | 0.157 |
| CYP3a4-inh | 0.022 |
| CYP3a4-sub | 0.275 |
| CL | 11.388 |
| T12 | 0.827 |
| hERG | 0.013 |
| Ames | 0.01 |
| ROA | 0.053 |
| SkinSen | 0.721 |
| Carcinogencity | 0.168 |
| EI | 0.99 |
| Respiratory | 0.054 |
| NR-Aromatase | 0.003 |
| Antiviral | Yes |
| Prediction | 0.581317 |